Primary melanoma tumors from CDKN2A mutation carriers do not belong to a distinct molecular subclass.
Staaf J, Harbst K, Lauss M, Ringnér M, Måsbäck A, Howlin J, Jirström K, Harland M, Zebary A, Palmer JM, Ingvar C, Olsson H, Newton-Bishop J, Hansson J, Hayward N, Gruis N, Jönsson G.
Staaf J, et al.
J Invest Dermatol. 2014 Dec;134(12):3000-3003. doi: 10.1038/jid.2014.272. Epub 2014 Jul 7.
J Invest Dermatol. 2014.
PMID: 24999598
Free article.
No abstract available.